Devon was diagnosed at two years old with Stage IV MYCN amplified Neuroblastoma with bone and liver metastases. Devon’s mum, Deborah tells their story so far:
Neuroblastoma is one of the most common solid tumours affecting children, and remains very difficult to treat. Several studies have already used Next Generation Sequencing (NGS) to examine somatic alterations (the changes in DNA which can happen in the body’s cells which can cause cancer) to try to identify what causes neuroblastoma to form.
NGS has given scientists some amazing ...
Neuroblastoma is one of the most common solid tumours affecting children, and these days some forms of it are very treatable. But in high risk types, long-term survival rates are only 50%, particularly when a child has had chemotherapy treatment but their cancer has relapsed.
There is evidence to suggest that some chemotherapy treatments actually increase the likelihood of the ...
Jessica was diagnosed at three years old with a localised neuroblastoma. Jess’ guardian, Louise, tells their story so far:
Neuroblastoma is one of the most common solid tumours to occur in children. It can be exceptionally difficult to treat and, despite intensive treatment, around one third of patients cannot currently be cured. In this project, Dr Gilham is harnessing the power of the immune system by engineering specific immune cells to destroy tumour cells. He will lay the essential ...
Read moreNeuroblastoma, one of the most common childhood cancers, is often not diagnosed until it has spread to other parts of the body. At this stage it is very difficult to treat. A form of radiotherapy known as MIBG therapy has generated long-term remissions but cannot cure advanced disease. Professor Mairs is exploring the use of MIBG therapy in combination with ...
Read more